1. Home
  2. CIGI vs TLX Comparison

CIGI vs TLX Comparison

Compare CIGI & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIGI
  • TLX
  • Stock Information
  • Founded
  • CIGI 1972
  • TLX 2015
  • Country
  • CIGI Canada
  • TLX Australia
  • Employees
  • CIGI N/A
  • TLX N/A
  • Industry
  • CIGI
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIGI
  • TLX Health Care
  • Exchange
  • CIGI Nasdaq
  • TLX Nasdaq
  • Market Cap
  • CIGI 6.0B
  • TLX 5.7B
  • IPO Year
  • CIGI N/A
  • TLX N/A
  • Fundamental
  • Price
  • CIGI $120.48
  • TLX $16.99
  • Analyst Decision
  • CIGI Buy
  • TLX Strong Buy
  • Analyst Count
  • CIGI 7
  • TLX 1
  • Target Price
  • CIGI $157.43
  • TLX $22.00
  • AVG Volume (30 Days)
  • CIGI 149.0K
  • TLX 20.6K
  • Earning Date
  • CIGI 05-06-2025
  • TLX 01-01-0001
  • Dividend Yield
  • CIGI 0.25%
  • TLX N/A
  • EPS Growth
  • CIGI 38.82
  • TLX 798.14
  • EPS
  • CIGI 2.86
  • TLX 0.09
  • Revenue
  • CIGI $4,961,214,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • CIGI $13.69
  • TLX N/A
  • Revenue Next Year
  • CIGI $6.68
  • TLX N/A
  • P/E Ratio
  • CIGI $42.07
  • TLX $183.81
  • Revenue Growth
  • CIGI 13.50
  • TLX 55.85
  • 52 Week Low
  • CIGI $100.86
  • TLX $13.61
  • 52 Week High
  • CIGI $156.96
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • CIGI 48.35
  • TLX N/A
  • Support Level
  • CIGI $116.50
  • TLX N/A
  • Resistance Level
  • CIGI $122.29
  • TLX N/A
  • Average True Range (ATR)
  • CIGI 2.65
  • TLX 0.00
  • MACD
  • CIGI -0.64
  • TLX 0.00
  • Stochastic Oscillator
  • CIGI 28.74
  • TLX 0.00

About CIGI Colliers International Group Inc. Subordinate Voting Shares

Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: